DIS3 licenses B cells for plasma cell differentiation in humans
本研究揭示了DIS3在B细胞增殖和浆细胞分化中的关键作用，缺失DIS3会导致基因组不稳定，影响免疫球蛋白的分泌。DIS3基因突变在多发性骨髓瘤患者中频繁出现，并与患者预后相关，表明其作为潜在治疗靶点的重要性。研究结果为理解浆细胞发育及其在肿瘤中的作用提供了新的视角，具有重要的临床和商业价值。
Glucose starvation mimetic aldometanib removes immune barriers permitting mice with hepatocellular carcinoma to live to normal ages
Aldometanib, a glucose starvation mimetic, shows promise in treating hepatocellular carcinoma (HCC) by activating AMPK and enhancing the immune response. In mouse models, it significantly inhibits tumor growth and allows mice to live to normal ages, indicating a potential breakthrough in cancer therapy. The study highlights the metabolic intervention strategy as a novel approach to managing cancer, suggesting that metabolic regulation can transform cancer into a manageable disease.
Sarepta gets FDAs go-ahead to study immunosuppressive Elevidys regimen in bid to reverse label restriction
Sarepta Therapeutics获得FDA批准，开展一项新的临床试验，评估sirolimus在DMD基因治疗中的应用，以降低肝损伤风险。该研究旨在为非独立行走的患者恢复治疗机会提供新的路径，可能对市场产生积极影响。
The prognostic value and functional role of CPSF3 in hepatocellular carcinoma
CPSF3被发现是肝细胞癌（HCC）的重要生物标志物，其在HCC组织中的表达显著上调，且与疾病的进展及患者预后密切相关。通过多组学分析，研究表明CPSF3不仅在HCC细胞中促进增殖和迁移，还与免疫细胞浸润及细胞周期、MAPK信号通路相关联。这些发现为CPSF3作为HCC的诊断和预后生物标志物提供了有力支持，具有潜在的治疗靶点价值。
Pharma pros skeptical of letting AI loose on regulatory compliance submissions: survey
一项调查显示，制药行业对AI在合规提交中的应用持怀疑态度，65%的受访者不信任AI生成的材料。尽管如此，55%的公司正在探索AI以提高效率，显示出对技术应用的潜在需求。调查还指出，行业对AI的信任在材料审核等低风险领域相对较高。
Novartis scores FDA approval for new version of SMA gene therapy, prices at $2.59M
Novartis的Itvisma获得FDA批准，成为针对脊髓性肌萎缩症(SMA)的基因疗法，覆盖所有年龄段患者。该疗法通过脊髓注射直接作用于中枢神经系统，预计将显著改善患者的运动功能。Itvisma的定价为259万美元，较现有治疗方案更具竞争力。Novartis预计该产品将实现数十亿美元的销售，并通过收购增强在神经肌肉疾病领域的投资。
STAT+: Pharmalittle: We’re reading about a Novo next-gen diabetes drug, a Novartis gene therapy, and more
Novo Nordisk的下一代糖尿病药物amycretin在Ⅱ期临床试验中表现出良好的疗效，帮助患者降低血糖和减重。该药物将于明年启动Ⅲ期研究。同时，Novartis的基因疗法Itvisma获得FDA批准，适用于脊髓性肌萎缩症的老年患者，标志着在罕见病治疗领域的重大进展。
Atovaquone-induced oxidative stress activates the pentose phosphate pathway and Immunogenic cell death in ovarian cancer
Atovaquone, an FDA-approved oxidative phosphorylation inhibitor, shows promise in treating epithelial ovarian cancer (EOC) by inducing oxidative stress and activating immune responses. The study reveals that atovaquone disrupts cellular metabolism, activates the pentose phosphate pathway, and enhances immunogenic cell death, making EOC cells more susceptible to treatment. Notably, atovaquone increases the expression of damage-associated molecular patterns (DAMPs) and enhances natural killer (NK) cell activity, suggesting its potential as a combination therapy in EOC treatment. These findings pave the way for further exploration of atovaquone in cancer therapy.
FRA1 drives melanoma metastasis through an actionable transcriptional network
FRA1 is identified as a key driver of melanoma metastasis, enhancing the ability of melanoma cells to colonize and grow in distant organs. The study reveals a transcriptional network controlled by FRA1 that includes AXL, CDK6, and FSCN1, which are associated with poor patient outcomes. Targeting these pathways may provide new therapeutic strategies for treating metastatic melanoma.
Elovl7 sensitizes podocytes to ferroptosis in podocytopathy by elongating polyunsaturated fatty acids
研究发现，Elovl7在肾小管病中通过延长多不饱和脂肪酸使肾小管细胞对铁死亡敏感。通过单细胞RNA测序分析，研究者揭示了Elovl7在肾小管损伤中的上调及其对脂质代谢的影响，提示其可能成为治疗肾小管病的新靶点。该研究为理解肾小管病的发病机制提供了新的视角，并可能推动相关药物的开发。
Necrotic and apoptotic adipocytes in the hypoxic tumor microenvironment supply triglycerides to induce cisplatin resistance in the metastatic lymph nodes of head and neck carcinoma
本研究探讨了颈部淋巴结转移的头颈部鳞状细胞癌（HNSCC）中，脂肪细胞如何通过释放甘油三酯来促进肿瘤对顺铂的耐药性。研究发现，缺氧微环境导致脂肪细胞的凋亡和坏死，从而增加甘油三酯的释放，进而影响肿瘤细胞的化疗反应。这一发现为HNSCC的治疗提供了新的思路，尤其是在改善化疗效果方面。
Proteomic discovery of DEK and NUMA1 as new players in UV-induced DNA damage repair mechanisms
本研究通过点击化学基础的蛋白质组学方法，发现DEK和NUMA1在UV诱导的DNA损伤修复中扮演重要角色。缺失这两种蛋白会导致UV损伤修复延迟，增加细胞对UV的敏感性，表明它们在核苷酸切除修复(NER)和长片段碱基切除修复(BER)中具有协同作用。这一发现为理解DNA修复机制提供了新视角，并可能为生物技术领域的应用奠定基础。
RB loss sensitizes triple-negative breast cancer to apoptosis induced by cellular stress
研究发现，RB缺失在三阴性乳腺癌(TNBC)中普遍存在，并导致对细胞周期抑制引起的细胞应激的增强敏感性。通过药物筛选，研究者发现RB缺失模型对多种细胞周期靶向药物表现出显著的敏感性，尤其是联合使用药物时，能够有效诱导凋亡。这一发现为RB缺失的TNBC提供了新的靶向治疗策略，具有重要的临床应用潜力。
CRISPR/Cas9-mediated gene editing in trophoblast cells via mechanoporation for preeclampsia insight
该研究探讨了CRISPR/Cas9技术在滋养层细胞中的应用，针对妊娠高血压的潜在生物标志物FKBPL进行基因编辑。通过开发一种新型机械穿孔系统，研究者成功提高了基因编辑效率，部分基因敲除模型揭示了FKBPL在妊娠高血压中的重要作用，为相关疾病的治疗提供了新的思路和策略。
Metformin protects retinal ganglion cells in a preclinical model of retinal ischemia/reperfusion injury and stabilizes visual field in diabetic patients with glaucoma
Metformin, a widely used diabetes medication, demonstrates neuroprotective effects in retinal ganglion cells, crucial for vision. In a preclinical mouse model of retinal ischemia/reperfusion injury, metformin significantly reduced retinal ganglion cell loss and preserved retinal structure. Clinically, diabetic patients with glaucoma treated with metformin maintained stable visual field parameters over six months, contrasting with deterioration in those treated with insulin. These findings suggest metformin's potential as a therapeutic agent in glaucoma management, warranting further investigation into its mechanisms and efficacy.